Unlike Ozempic, which is FDA approved to treat Type 2 diabetes, Wegovy is approved for weight loss in patients with a body mass index (BMI) of 30 or higher and in patients with a BMI of 27 or higher who also have a weight-related medical condition like Type 2 diabetes, high blood pressure, or high cholesterol
Whats the best way to track progress beyond the scale
Furthermore, GLP-1RAs exhibit substantial weight reduction effects by facilitating glucose uptake and suppressing appetite [6]
No injections, no stimulants
These effects last for up to two years if you keep taking the medication
In the past, weight loss medications didnt produce dramatic weight loss, so a very low percentage of patients who might have benefited used them, Low Wang said